Business of Medicine
Feature
Luxe vacations, private jets: Medical device maker, surgeon to pay $46 million penalty in kickback scheme
“In recent years, we are seeing a trend toward holding physicians and others on the receiving end of the inducement accountable as well,”...
Feature
Dabigatran recalled over potential carcinogen
The nationwide recall is because of the detection of the nitrosamine impurity, N-nitroso-dabigatran.
From the Journals
Tooth loss and diabetes together hasten mental decline
The findings of a new study show “the importance of improving access to dental health care and integrating primary dental and medical care,”...
Commentary
Celebrity death finally solved – with locks of hair
Case: A 56-year-old musician presents with diffuse abdominal pain, cramping, and jaundice. His medical history is notable for years of diffuse...
Feature
Nurse makes millions selling her licensing exam study sheets
Stephanee Beggs’ business developed in a “very unintentional” way.
News from the FDA/CDC
Prostate cancer drug shortage leaves some with uncertainty
The therapy lutetium Lu 177 vipivotide tetraxetan will remain in limited supply until the drug’s manufacturer can ramp up production.
Feature
After the Match: Next steps for new residents, unmatched
International medical graduates applied in record numbers to Match2023, according to the National Resident Matching Program.
Feature
Old-school printer helps scientists quickly spot bacteria in blood
An inkjet printer has been modified to print blood instead of ink.
Feature
State medical board chair steps down amid Medicaid fraud accusations
State officials have suspended all Medicaid payments to Dr. Brian T. Hyatt and his practice.
Feature
Liquid albuterol shortage effects reduced by alternative drugs, similar shortages may be increasingly common
The shortage of 0.5% albuterol sulfate inhalation solution gained increased attention earlier this month when Akorn Pharmaceuticals – one of just...
Feature
California picks generic drug company Civica to produce low-cost insulin
Gov. Gavin Newsom, who blasted pharmaceutical companies for gouging Californians, is moving ahead with state-branded insulin.